CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Albuterol Sulfate Solution
FDA source answer
FDA source rows are resolved or no longer current.
FDA source statuses: Resolved. First FDA posting: 2022-10-25. Latest FDA row update: 2026-08-27.
FDA lists 3 package records, with companies: Nephron Pharmaceuticals Corporation, Rising Pharma Holdings, Inc., Ritedose Pharmaceuticals, LLC. Package NDCs: 0487-9901-30, 64980-642-03, 76204-027-01.
FDA shortage reason: Not stated in the grouped FDA source rows.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| Nephron Pharmaceuticals Corporation | 0487-9901-30 | Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 0487-9901-30) | Not stated | 2026-08-27 |
| Rising Pharma Holdings, Inc. | 64980-642-03 | Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 64980-642-03) | Not stated | 2026-08-27 |
| Ritedose Pharmaceuticals, LLC | 76204-027-01 | Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 76204-027-01) | Not stated | 2026-08-27 |
Source facts
Grouped generic ingredient: Albuterol Sulfate Solution · 3 package records
Therapeutic categories: Pediatric, Pulmonary/Allergy
Dosage forms: Solution
Routes: RESPIRATORY (INHALATION)
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.